Abstract
Cytomegaloviruses (CMV) are ubiquitous, opportunistic DNA viruses that have mastered the art of immune evasion through their ability to mimic host proteins or to inhibit antiviral responses. The study of the host response against CMV infection has illuminated many facets of the complex interaction between host and pathogen. Here, we review evidence derived from the animal models and human studies that supports the central role played by innate immune receptors in the recognition of virus infection and their participation in the many layers of defense.
Similar content being viewed by others
References
Andrews DM, Andoniou CE, Scalzo AA, van Dommelen SL, Wallace ME et al (2005) Cross-talk between dendritic cells and natural killer cells in viral infection. Mol Immunol 42:547–555
Arapovic J, Lenac T, Antulov R, Polic B, Ruzsics Z et al (2009) Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J Virol 83:8198–8207
Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323–1326
Barbalat R, Lau L, Locksley RM, Barton GM (2009) Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 10:1200–1207
Beutler B, Crozat K, Koziol JA, Georgel P (2005) Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model. Curr Opin Immunol 17:36–43
Blasius AL, Beutler B (2010) Intracellular toll-like receptors. Immunity 32:305–315
Boehme KW, Guerrero M, Compton T (2006) Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 177:7094–7102
Bottino C, Castriconi R, Pende D, Rivera P, Nanni M et al (2003) Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198:557–567
Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL et al (2007) The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 177:265–275
Bubic I, Wagner M, Krmpotic A, Saulig T, Kim S et al (2004) Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78:7536–7544
Burckstummer T, Baumann C, Bluml S, Dixit E, Durnberger G et al (2009) An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10:266–272
Campbell JA, Trossman DS, Yokoyama WM, Carayannopoulos LN (2007) Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J Exp Med 204:1311–1317
Carlyle JR, Mesci A, Fine JH, Chen P, Belanger S et al (2008) Evolution of the Ly49 and Nkrp1 recognition systems. Semin Immunol 20:321–330
Carvalho A, Cunha C, Carotti A, Aloisi T, Guarrera O et al (2009) Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Exp Hematol 37:1022–1029
Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A et al (2006) Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308–312
Champsaur M, Lanier LL (2010) Effect of NKG2D ligand expression on host immune responses. Immunol Rev 235:267–285
Chapman TL, Heikeman AP, Bjorkman PJ (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11:603–613
Cheng TP, French AR, Plougastel BF, Pingel JT, Orihuela MM et al (2008) Ly49 h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics 60:565–573
Cretney E, Degli-Esposti MA, Densley EH, Farrell HE, Davis-Poynter NJ et al (1999) m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J Expe Med 190:435–444
Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC et al (2003) Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 197:885–898
DeFilippis VR, Alvarado D, Sali T, Rothenburg S, Fruh K (2010) Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J Virol 84:585–598
Desrosiers MP, Kielczewska A, Loredo-Osti JC, Adam SG, Makrigiannis AP et al (2005) Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 37:593–599
Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK et al (2002) Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 3:1142–1149
Dietrich N, Lienenklaus S, Weiss S, Gekara NO (2010) Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS One 5:e10250
Dighe A, Rodriguez M, Sabastian P, Xie X, McVoy M et al (2005) Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J Immunol 175:6820–6828
Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR et al (1997) Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510–514
Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458:509–513
Fodil-Cornu N, Lee SH, Belanger S, Makrigiannis AP, Biron CA et al (2008) Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J Immunol 181:6394–6405
French AR, Pingel JT, Wagner M, Bubic I, Yang L et al (2004) Escape of mutant double-stranded DNA virus from innate immune control. Immunity 20:747–756
Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA (2008) The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 59:343–359
Garrigue I, Corte MF, Magnin N, Couzi L, Capdepont S et al (2007) Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients. J Clin Virol 40:120–128
Garrigue I, Faure-Della Corte M, Magnin N, Recordon-Pinson P, Couzi L et al (2008) UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients. Transplantation 86:826–835
Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N et al (2004) Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104:3664–3671
Guma M, Budt M, Saez A, Brckalo T, Hengel H et al (2006) Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107:3624–3631
Gunturi A, Berg RE, Forman J (2004) The role of CD94/NKG2 in innate and adaptive immunity. Immunol Res 30:29–34
Hoebe K, Du X, Georgel P, Janssen E, Tabeta K et al (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743–748
Hornung V, Latz E (2010) Intracellular DNA recognition. Nat Rev Immunol 10:123–130
Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G et al (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458:514–518
Iizuka K, Naidenko OV, Plougastel BF, Fremont DH, Yokoyama WM (2003) Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 4:801–807
Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674–678
Jonjic S, Babic M, Polic B, Krmpotic A (2008) Immune evasion of natural killer cells by viruses. Curr Opin Immunol 20:30–38
Kelley J, Walter L, Trowsdale J (2005) Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet 1:129–139
Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB et al (2009) Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med 206:515–523
Kim YM, Brinkmann MM, Paquet ME, Ploegh HL (2008) UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452:234–238
Krug A, French AR, Barchet W, Fischer JA, Dzionek A et al (2004) TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21:107–119
Kulkarni S, Martin MP, Carrington M (2008) The Yin and Yang of HLA and KIR in human disease. Semin Immunol 20:343–352
Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225–274
Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9:495–502
Lee SH, Zafer A, de Repentigny Y, Kothary R, Tremblay ML et al (2003) Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med 197:515–526
Lenac T, Arapovic J, Traven L, Krmpotic A, Jonjic S (2008) Murine cytomegalovirus regulation of NKG2D ligands. Med Microbiol Immunol 197:159–166
Ljunggren HG, Karre K (1985) Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 162:1745–1759
Loewendorf A, Benedict CA (2010) Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J Intern Med 267:483–501
Mans J, Natarajan K, Balbo A, Schuck P, Eikel D et al (2007) Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153. J Biol Chem 282:35247–35258
Mocarski ES Jr (2002) Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10:332–339
Mocarski ES Jr (2004) Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol 6:707–717
Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O (2009) Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5:376–385
Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH (2002) Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 20:853–885
Natarajan K, Hicks A, Mans J, Robinson H, Guan R et al (2006) Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol 358:157–171
Orange JS (2002) Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 4:1545–1558
Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D et al (2008) CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med 205:725–735
Prod’homme V, Sugrue DM, Stanton RJ, Nomoto A, Davies J et al (2010) Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112. J Gen Virol 91:2034–2039
Pyzik M, Kielczewska A, Vidal SM (2008) NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome. Semin Immunol 20:331–342
Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE et al (2010) The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11:395–402
Rebsamen M, Heinz LX, Meylan E, Michallet MC, Schroder K et al (2009) DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep 10:916–922
Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM et al (2009) HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323:1057–1060
Salazar-Mather TP, Orange JS, Biron CA (1998) Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med 187:1–14
Scalzo AA, Yokoyama WM (2008) Cmv1 and natural killer cell responses to murine cytomegalovirus infection. Curr Top Microbiol Immunol 321:101–122
Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR (1990) Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 171:1469–1483
Shellam GR, Allan JE, Papadimitriou JM, Bancroft GJ (1981) Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci USA 78:5104–5108
Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87:1763–1779
Sjölin H, Tomasello E, Mousavi-Jazi M, Bartolazzi A, Kärre K et al (2002) Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J Exp Med 195(7):825–834
Soderberg-Naucler C (2006) Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 259:219–246
Szomolanyi-Tsuda E, Liang X, Welsh RM, Kurt-Jones EA, Finberg RW (2006) Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol 80:4286–4291
Tabeta K, Georgel P, Janssen E, Du X, Hoebe K et al (2004) Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101:3516–3521
Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P et al (2006) The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 7:156–164
Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H et al (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501–505
Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP et al (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031
Tomasec P, Wang EC, Davison AJ, Vojtesek B, Armstrong M et al (2005) Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol 6:181–188
Upton JW, Kaiser WJ, Mocarski ES (2010) Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7:302–313
Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HR et al (2003) Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci USA 100:13483–13488
Voigt S, Mesci A, Ettinger J, Fine JH, Chen P et al (2007) Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. Immunity 26:617–627
Wang N, Baldi PF, Gaut BS (2007) Phylogenetic analysis, genome evolution and the rate of gene gain in the Herpesviridae. Mol Phylogenet Evol 43:1066–1075
Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod’homme V et al (2008) Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 41:206–212
Zafirova B, Mandaric S, Antulov R, Krmpotic A, Jonsson H et al (2009) Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 31:270–282
Zahringer U, Lindner B, Inamura S, Heine H, Alexander C (2008) TLR2—promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213:205–224
Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G et al (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522–1527
Zuniga J, Romero V, Azocar J, Terreros D, Vargas-Rojas MI et al (2009) Protective KIR-HLA interactions for HCV infection in intravenous drug users. Mol Immunol 46:2723–2727
Acknowledgments
We apologize to our colleagues who were not cited here due to lack of space. This work was supported by the Canadian Institutes of Health Research MOP-7781, as well as the Canadian Institutes of Health Doctoral Scholarship (M. Pyzik) and the Canada Research Chairs Program (S. M. Vidal).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pyzik, M., Gendron-Pontbriand, EM., Fodil-Cornu, N. et al. Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors. Mamm Genome 22, 6–18 (2011). https://doi.org/10.1007/s00335-010-9286-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-010-9286-2